J.F. Colombel

Ineffectiveness of <i>Lactobacillus johnsonii</i> LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

Philippe Marteau, Marc Lémann, Philippe Seksik et al. · Gut · 2005 · 409 citations · Full text

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 320 citations · Full text

Association between polymorphism in IgG Fc receptor IIIa coding gene and biological response to infliximab in Crohn's disease

Édouard Louis, Z. El Ghoul, Séverine Vermeire et al. · Alimentary Pharmacology & Therapeutics · 2004 · 219 citations · Full text

The changing pattern of Crohn’s disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)

Vincent Chouraki, Guillaume Savoye, Luc Dauchet et al. · Alimentary Pharmacology & Therapeutics · 2011 · 166 citations · Full text

Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease

Remo Panaccione, J.F. Colombel, William J. Sandborn et al. · Alimentary Pharmacology & Therapeutics · 2010 · 105 citations